Mechanism and Application of Vitamin D in Idiopathic Sudden Sensorineural Hearing Loss

NAActive, not recruitingINTERVENTIONAL
Enrollment

197

Participants

Timeline

Start Date

June 1, 2025

Primary Completion Date

June 1, 2026

Study Completion Date

June 1, 2026

Conditions
Idiopathic Sudden Sensorineural Hearing Loss
Interventions
DRUG

Vitamin D Supplementation+ standard treatment

The experimental group was tested for 25(OH)D concentration after enrollment, and the experimental group was divided into vitamin D deficiency group and vitamin D normal group. In the vitamin D-deficient group, participants will receive standard treatment plus oral vitamin D3 supplementation (800 IU daily for 4 weeks), whereas the vitamin D normal group will receive standard treatment alone

OTHER

standard treatment

The experimental group was tested for 25(OH)D concentration after enrollment, and the experimental group was divided into vitamin D deficiency group and vitamin D normal group. The vitamin D normal group will receive standard treatment alone

Trial Locations (1)

361004

Zhongshan Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen

All Listed Sponsors
lead

Zhongshan Hospital Xiamen University

OTHER